Published in Mol Cell Biol on December 01, 1993
Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol (1995) 6.26
Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci U S A (1997) 5.83
Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev (2000) 3.72
Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev (2007) 3.41
E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol (1996) 3.40
E2f3 is critical for normal cellular proliferation. Genes Dev (2000) 3.26
E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci U S A (1995) 2.99
Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol Cell Biol (1994) 2.95
Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis. Mol Cell Biol (2001) 2.85
CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol Cell Biol (1999) 2.84
Structural basis of DNA recognition by the heterodimeric cell cycle transcription factor E2F-DP. Genes Dev (1999) 2.73
Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J (1996) 2.63
The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol Cell Biol (1996) 2.47
Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol Cell Biol (1996) 2.46
Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol Cell Biol (1994) 2.44
Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol Cell Biol (1996) 2.44
A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc Natl Acad Sci U S A (1996) 2.36
Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol Cell Biol (1993) 2.34
E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol Cell Biol (1997) 2.33
PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev (1997) 2.29
Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol Cell Biol (1997) 2.27
E2F-5, a new E2F family member that interacts with p130 in vivo. Mol Cell Biol (1995) 2.26
Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest (1996) 2.21
Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J (1994) 2.14
DNA-binding and trans-activation properties of Drosophila E2F and DP proteins. Proc Natl Acad Sci U S A (1994) 2.08
Cell cycle-regulated expression of mammalian CDC6 is dependent on E2F. Mol Cell Biol (1998) 2.07
Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals. Mol Cell Biol (1997) 2.00
In vivo association of E2F and DP family proteins. Mol Cell Biol (1995) 1.99
E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc Natl Acad Sci U S A (1998) 1.99
The transcription factor E2F-1 is a downstream target of RB action. Mol Cell Biol (1995) 1.97
In vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression. Mol Cell Biol (1995) 1.93
Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol Cell Biol (1995) 1.87
Multiple members of the E2F transcription factor family are the products of oncogenes. Proc Natl Acad Sci U S A (1995) 1.86
Expression of the HsOrc1 gene, a human ORC1 homolog, is regulated by cell proliferation via the E2F transcription factor. Mol Cell Biol (1996) 1.83
A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci U S A (1995) 1.82
Analysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-associated E2F-1. J Virol (1993) 1.78
Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor. Mol Cell Biol (2003) 1.76
Genetic characterization of a mammalian protein-protein interaction domain by using a yeast reverse two-hybrid system. Proc Natl Acad Sci U S A (1996) 1.72
Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival. Br J Cancer (1999) 1.71
Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor. Genes Dev (2002) 1.70
Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. Proc Natl Acad Sci U S A (1999) 1.67
The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J (1995) 1.67
Functional properties of a Drosophila homolog of the E2F1 gene. Mol Cell Biol (1994) 1.67
Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins. Mol Cell Biol (2000) 1.66
Lamin A/C binding protein LAP2alpha is required for nuclear anchorage of retinoblastoma protein. Mol Biol Cell (2002) 1.64
Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1. Mol Cell Biol (1996) 1.62
Ectopic expression of dE2F and dDP induces cell proliferation and death in the Drosophila eye. EMBO J (1996) 1.61
Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins. Mol Cell Biol (1995) 1.61
Regulation of the retinoblastoma protein-related protein p107 by G1 cyclin-associated kinases. Proc Natl Acad Sci U S A (1996) 1.51
E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas. Mol Cell Biol (2003) 1.50
The retinoblastoma family of proteins and their regulatory functions in the mammalian cell division cycle. Cell Div (2012) 1.46
Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo. Mol Cell Biol (2002) 1.44
Cumulative effect of phosphorylation of pRB on regulation of E2F activity. Mol Cell Biol (1999) 1.42
p130 is dispensable in peripheral T lymphocytes: evidence for functional compensation by p107 and pRB. Mol Cell Biol (1998) 1.39
Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol Cell Biol (1996) 1.37
Requirements for dE2F function in proliferating cells and in post-mitotic differentiating cells. EMBO J (1996) 1.33
Complex transcriptional regulatory mechanisms control expression of the E2F3 locus. Mol Cell Biol (2000) 1.32
E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis. Mol Cell Biol (2002) 1.30
Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc Natl Acad Sci U S A (1996) 1.29
Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice. J Clin Invest (2004) 1.29
Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F. J Virol (1996) 1.27
Position-dependent transcriptional regulation of the murine dihydrofolate reductase promoter by the E2F transactivation domain. Mol Cell Biol (1997) 1.26
Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification. Oncogene (2007) 1.22
E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol Cell Biol (1995) 1.20
Heterodimerization of the transcription factors E2F-1 and DP-1 is required for binding to the adenovirus E4 (ORF6/7) protein. J Virol (1994) 1.18
Transcriptional repression and growth suppression by the p107 pocket protein. Mol Cell Biol (1996) 1.18
Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins. Mol Cell Biol (1997) 1.18
p21 Disrupts the interaction between cdk2 and the E2F-p130 complex. Mol Cell Biol (1996) 1.16
Expression-based Pathway Signature Analysis (EPSA): mining publicly available microarray data for insight into human disease. BMC Med Genomics (2008) 1.16
Protein-DNA interactions at the major and minor promoters of the divergently transcribed dhfr and rep3 genes during the Chinese hamster ovary cell cycle. Mol Cell Biol (1996) 1.15
Pocket protein-independent repression of urokinase-type plasminogen activator and plasminogen activator inhibitor 1 gene expression by E2F1. Mol Cell Biol (2000) 1.14
v-Abl activates c-myc transcription through the E2F site. Mol Cell Biol (1995) 1.13
Multiple change in E2F function and regulation occur upon muscle differentiation. Mol Cell Biol (1995) 1.10
E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes. Mol Cell Biol (1996) 1.09
Novel mechanisms of E2F induction by BK virus large-T antigen: requirement of both the pRb-binding and the J domains. Mol Cell Biol (1998) 1.09
Mitogenic Sonic hedgehog signaling drives E2F1-dependent lipogenesis in progenitor cells and medulloblastoma. Oncogene (2010) 1.09
Expression of p57(KIP2) potently blocks the growth of human astrocytomas and induces cell senescence. Am J Pathol (2000) 1.07
Selective requirements for E2f3 in the development and tumorigenicity of Rb-deficient chimeric tissues. Mol Cell Biol (2007) 1.07
Functional interaction between DP-1 and p53. Mol Cell Biol (1996) 1.06
Cell-context specific role of the E2F/Rb pathway in development and disease. Glia (2010) 1.04
Mutually exclusive interaction of the adenovirus E4-6/7 protein and the retinoblastoma gene product with internal domains of E2F-1 and DP-1. J Virol (1994) 1.03
Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer. PLoS One (2013) 1.03
Inhibition of E2F-mediated transcription by p202. EMBO J (1996) 1.02
A role for a bent DNA structure in E2F-mediated transcription activation. Mol Cell Biol (1996) 1.00
Transcription of histone H4, H3, and H1 cell cycle genes: promoter factor HiNF-D contains CDC2, cyclin A, and an RB-related protein. Proc Natl Acad Sci U S A (1994) 1.00
Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome. Br J Cancer (2009) 0.99
The role of the apoptotic machinery in tumor suppression. Cold Spring Harb Perspect Biol (2012) 0.97
miR-210: fine-tuning the hypoxic response. Adv Exp Med Biol (2014) 0.95
Accumulation of human papillomavirus type 16 E7 protein bypasses G1 arrest induced by serum deprivation and by the cell cycle inhibitor p21. J Virol (1997) 0.95
Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo. J Clin Invest (1998) 0.94
E2F3 plays an essential role in cardiac development and function. Cell Cycle (2008) 0.94
Bok, Bcl-2-related Ovarian Killer, Is Cell Cycle-regulated and Sensitizes to Stress-induced Apoptosis. J Biol Chem (2006) 0.93
The retinoblastoma protein-associated cell cycle arrest in S-phase under moderate hypoxia is disrupted in cells expressing HPV18 E7 oncoprotein. Br J Cancer (1998) 0.93
HypoxamiRs and cancer: from biology to targeted therapy. Antioxid Redox Signal (2013) 0.92
Nerve growth factor regulates the expression and activity of p33cdk2 and p34cdc2 kinases in PC12 pheochromocytoma cells. Mol Biol Cell (1994) 0.91
The role of hypoxia-induced miR-210 in cancer progression. Int J Mol Sci (2015) 0.91
Molecular characterization of Xenopus laevis DP proteins. Mol Biol Cell (1994) 0.89
Subcellular compartmentalization of E2F family members is required for maintenance of the postmitotic state in terminally differentiated muscle. J Cell Biol (2000) 0.88
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci U S A (1972) 83.88
Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem (1977) 72.51
Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing. Gene (1984) 56.23
Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol (1987) 26.70
Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol (1981) 15.59
Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell (1989) 14.24
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (1986) 13.96
E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science (1992) 10.28
The E2F transcription factor is a cellular target for the RB protein. Cell (1991) 9.62
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell (1992) 9.19
Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc Natl Acad Sci U S A (1988) 7.48
The role of the leucine zipper in the fos-jun interaction. Nature (1988) 7.44
Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science (1987) 6.93
Identification of a cellular transcription factor involved in E1A trans-activation. Cell (1986) 6.36
Fos-associated protein p39 is the product of the jun proto-oncogene. Science (1988) 6.34
A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell (1992) 6.32
DNA binding activities of three murine Jun proteins: stimulation by Fos. Cell (1988) 6.13
The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev (1992) 5.73
Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev (1993) 5.54
Retinoblastoma protein switches the E2F site from positive to negative element. Nature (1992) 5.47
The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell (1992) 5.05
Structural evidence for the authenticity of the human retinoblastoma gene. Science (1987) 4.67
Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature (1991) 4.62
A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eucaryotic cells. Anal Biochem (1986) 4.60
Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science (1988) 4.54
The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F. Cell (1991) 4.42
Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature (1992) 4.21
Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev (1993) 4.14
Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell (1991) 3.98
Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev (1992) 3.96
E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. Proc Natl Acad Sci U S A (1989) 3.67
A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex. Cell (1992) 3.64
Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol Cell Biol (1992) 3.58
Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science (1990) 3.58
Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol (1993) 3.54
Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter. Genes Dev (1989) 2.82
Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol Cell Biol (1992) 2.78
Interactions of the p107 and Rb proteins with E2F during the cell proliferation response. EMBO J (1993) 2.70
A new component of the transcription factor DRTF1/E2F. Nature (1993) 2.65
Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol Cell Biol (1993) 2.34
Adenovirus E1A targets key regulators of cell proliferation. Cancer Surv (1992) 2.29
Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides. Mol Cell Biol (1991) 2.20
The adenovirus EIIA enhancer. Analysis of regulatory sequences and changes in binding activity of ATF and EIIF following adenovirus infection. J Biol Chem (1989) 1.93
Thyroid hormone regulates the mouse thyrotropin beta-subunit gene promoter in transfected primary thyrotropes. J Biol Chem (1989) 1.84
Analysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-associated E2F-1. J Virol (1993) 1.78
Transcriptional repression by the Rb-related protein p107. Mol Biol Cell (1993) 1.72
Transcription factor E2F binds DNA as a heterodimer. Proc Natl Acad Sci U S A (1993) 1.53
The retinoblastoma gene and gene product. Cancer Surv (1992) 1.42
The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2. J Virol (1993) 1.29
The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc Natl Acad Sci U S A (1991) 1.29
Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells. Oncogene (1993) 1.15
Expression of the RB gene under the control of MuLV-LTR suppresses tumorigenicity of WERI-Rb-27 retinoblastoma cells in immunodefective mice. Cell Growth Differ (1990) 1.00
Reassignment of the human CSF1 gene to chromosome 1p13-p21. Blood (1991) 0.91
Chromosome 1 interphase-cytogenetics in 32 primary neuroblastomas of different clinical stages. Prog Clin Biol Res (1991) 0.82
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54
Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol (1981) 15.59
Protein interaction mapping in C. elegans using proteins involved in vulval development. Science (2000) 11.61
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (1988) 10.98
Distinct roles for cyclin-dependent kinases in cell cycle control. Science (1993) 8.13
Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J (1989) 7.69
Cellular targets for transformation by the adenovirus E1A proteins. Cell (1989) 7.53
GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes. Methods Enzymol (2000) 7.46
Correlation between transcriptome and interactome mapping data from Saccharomyces cerevisiae. Nat Genet (2001) 7.16
New functional activities for the p21 family of CDK inhibitors. Genes Dev (1997) 6.97
The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell (1989) 6.68
A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell (1992) 6.32
E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev (2001) 6.13
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol (2010) 5.96
Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products. J Virol (1985) 5.69
Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev (1993) 5.54
Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol (1994) 5.18
Identification of potential interaction networks using sequence-based searches for conserved protein-protein interactions or "interologs". Genome Res (2001) 5.10
Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell (1990) 5.06
A family of human cdc2-related protein kinases. EMBO J (1992) 4.96
Association of a murine 53,000-dalton phosphoprotein with simian virus 40 large-T antigen in transformed cells. J Virol (1980) 4.88
Tumor induction and tissue atrophy in mice lacking E2F-1. Cell (1996) 4.80
Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions. Proc Natl Acad Sci U S A (1996) 4.70
Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase. Nature (1991) 4.36
pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev (1997) 4.36
Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ (2000) 4.34
Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature (1992) 4.21
A dominant control region from the human beta-globin locus conferring integration site-independent gene expression. Nature (1989) 4.17
Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev (1993) 4.14
Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol Cell Biol (1986) 4.14
Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev (1998) 4.06
Open-reading-frame sequence tags (OSTs) support the existence of at least 17,300 genes in C. elegans. Nat Genet (2001) 4.03
Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev (1992) 3.96
p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature (1994) 3.95
Predictive factors of response to intravenous ciclosporin in severe ulcerative colitis: the development of a novel prediction formula. Aliment Pharmacol Ther (2012) 3.91
Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. Proc Natl Acad Sci U S A (1997) 3.66
Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev (1996) 3.61
Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol (1993) 3.54
Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell (2001) 3.49
Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev (1994) 3.47
Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature (1995) 3.41
Point mutational inactivation of the retinoblastoma antioncogene. Science (1989) 3.37
Identification of a family of human F-box proteins. Curr Biol (1999) 3.31
TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell (1997) 3.30
Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc Natl Acad Sci U S A (1998) 3.27
Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature (1997) 3.16
The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J (1991) 3.15
Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Mol Cell Biol (1985) 3.09
High-throughput yeast two-hybrid assays for large-scale protein interaction mapping. Methods (2001) 3.09
A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells. Cell (1989) 3.08
Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet (1996) 3.07
Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization. EMBO J (1999) 3.05
Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev (1997) 3.02
Two regions of the adenovirus early region 1A proteins are required for transformation. J Virol (1988) 3.02
Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet (1998) 3.01
E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci U S A (1995) 2.99
The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene (1993) 2.99
The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell (1989) 2.98
Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol (1992) 2.97
Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol (2001) 2.96
RBF, a novel RB-related gene that regulates E2F activity and interacts with cyclin E in Drosophila. Genes Dev (1996) 2.92
Hepatitis C virus infection protein network. Mol Syst Biol (2008) 2.91
NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev (2000) 2.90
CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol Cell Biol (1999) 2.84
Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron (2000) 2.82
The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J (1990) 2.80
Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage (2002) 2.78
Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature (1991) 2.78
A protein-protein interaction map of the Caenorhabditis elegans 26S proteasome. EMBO Rep (2001) 2.74
Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev (1996) 2.71
Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A (1996) 2.70
Enteropathogenic Escherichia coli associated with diarrhea in children and adults. Jpn J Med Sci Biol (1967) 2.62
p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev (1995) 2.60
The transcription factor E2F is required for S phase during Drosophila embryogenesis. Genes Dev (1995) 2.60
Complex of simian virus 40 large-T antigen and host 53,000-molecular-weight protein in monkey cells. J Virol (1981) 2.60
Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1. Genes Dev (2000) 2.58
Tissue specific and position independent expression of the complete gene domain for chicken lysozyme in transgenic mice. EMBO J (1990) 2.56
A novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteins. Proc Natl Acad Sci U S A (1996) 2.54
Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice. Nat Genet (1998) 2.53
Sequences 5' of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation (1994) 2.53
The yeast gene ERG6 is required for normal membrane function but is not essential for biosynthesis of the cell-cycle-sparking sterol. Mol Cell Biol (1989) 2.52
Yeast two-hybrid systems and protein interaction mapping projects for yeast and worm. Yeast (2000) 2.51
pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc Natl Acad Sci U S A (1998) 2.49
Nuclear organization of DNA replication in primary mammalian cells. Genes Dev (2000) 2.48
Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc Natl Acad Sci U S A (1995) 2.48
Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol Cell Biol (1996) 2.44
Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nat Genet (1993) 2.40